<p>The CCL5 receptor CCR5 is expressed in HSC-3 and SAS cells, but not in BMMSCs (A). rCCL5 can induce the expression of MMP9 in HSC-3 and SAS, but not in DOK cells (B). The silencing of the expression of CCR5 receptor in HSC-3 cells downregulates the gene expression about 70 % compared to control cells and blocks the signaling increasing the expression of MMP9 in cancer cells (C, D). CCR5 knockdown have minor or no effect on BMMSC enhanced invasion of HSC-3 cells in 3D organotypic model (E, F). </p
It has recently been suggested that the chemokine receptor (CCR5) is required for bone marrow (BM) d...
Despite the progress made in molecular and clinical research, patients with advanced-stage gastric c...
Background Cancer-induced 'emergency' myelopoiesis plays a key role in tumor progression by inducing...
<p>Co-culture of OTSCC cells with BMMSCs results in the high expression of chemokine CCL5 in HSC-3 a...
Background: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previo...
CCL5 (previously called RANTES) was originally recognized as a product of activated T cells, and pla...
BACKGROUND: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previo...
<div><h3>Background</h3><p>Osteosarcoma is characterized by a high malignant and metastatic potentia...
Until recently, inflammatory chemokines were viewed mainly as indispensable “gate keepers” of immuni...
We have recently analyzed the expression of the chemokine CCL5 and its receptors in human breast can...
Glioblastoma is the most frequent and aggressive brain tumour in humans with median survival from 12...
INTRODUCTION Chemokines and their cognate receptors play a major role in modulating inflammatory ...
We investigated the role of chemokines in regulating T cell accumulation in solid tumors. CCL5 and C...
Solid tumors are embedded in a stromal microenvironment consisting of immune cells, such as macropha...
Chemokines are responsible for directing leukocyte migration and triggering firm arrest by activatin...
It has recently been suggested that the chemokine receptor (CCR5) is required for bone marrow (BM) d...
Despite the progress made in molecular and clinical research, patients with advanced-stage gastric c...
Background Cancer-induced 'emergency' myelopoiesis plays a key role in tumor progression by inducing...
<p>Co-culture of OTSCC cells with BMMSCs results in the high expression of chemokine CCL5 in HSC-3 a...
Background: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previo...
CCL5 (previously called RANTES) was originally recognized as a product of activated T cells, and pla...
BACKGROUND: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previo...
<div><h3>Background</h3><p>Osteosarcoma is characterized by a high malignant and metastatic potentia...
Until recently, inflammatory chemokines were viewed mainly as indispensable “gate keepers” of immuni...
We have recently analyzed the expression of the chemokine CCL5 and its receptors in human breast can...
Glioblastoma is the most frequent and aggressive brain tumour in humans with median survival from 12...
INTRODUCTION Chemokines and their cognate receptors play a major role in modulating inflammatory ...
We investigated the role of chemokines in regulating T cell accumulation in solid tumors. CCL5 and C...
Solid tumors are embedded in a stromal microenvironment consisting of immune cells, such as macropha...
Chemokines are responsible for directing leukocyte migration and triggering firm arrest by activatin...
It has recently been suggested that the chemokine receptor (CCR5) is required for bone marrow (BM) d...
Despite the progress made in molecular and clinical research, patients with advanced-stage gastric c...
Background Cancer-induced 'emergency' myelopoiesis plays a key role in tumor progression by inducing...